(redirected from Aerius)
Also found in: Dictionary, Wikipedia.


a nonsedating antihistamine (H1 receptor antagonist) used for treatment of allergic rhinitis and chronic idiopathic urticaria; administered orally.


Aerius (CA), Clarinex, Clarinex Reditabs, Neoclarityn (UK)

Pharmacologic class: Peripherally selective piperidine, selective histamine1-receptor antagonist

Therapeutic class: Antihistamine (nonsedating, second generation)

Pregnancy risk category C


Suppresses histamine release at peripheral histamine1-receptor sites


Syrup: 2.5 mg/5 ml

Tablets: 5 mg

Tablets (orally disintegrating): 2.5 mg, 5 mg

Indications and dosages

Seasonal and perennial allergic rhinitis; chronic idiopathic urticaria and allergies caused by indoor and outdoor allergens; pruritus; to reduce number and size of hives

Adults and children ages 12 and older: 5 mg/day P.O.

Children ages 6 to 11: 1 tsp (2.5 mg/5 ml syrup) P.O. once daily

Children ages 12 months to 5 years: ⁄2 tsp (1.25 mg in 2.5 ml syrup) P.O. once daily

Children ages 6 to 11 months: 2 ml (1 mg syrup) P.O. once daily

Dosage adjustment

• Hepatic or renal impairment


• Hypersensitivity to drug, its components, or loratadine


Use cautiously in:
• renal or hepatic impairment
• elderly patients
• pregnant or breastfeeding patients
• children younger than age 12 (safety and efficacy not established, except syrup).


• Give with or without food.

Adverse reactions

CNS: dizziness, drowsiness, fatigue, headache

CV: tachycardia, palpitations

EENT: pharyngitis, dry throat

GI: nausea, dyspepsia, dry mouth

GU: dysmenorrhea

Musculoskeletal: myalgia

Other: flulike symptoms, hypersensitivity reaction


Drug-diagnostic tests.Bilirubin, hepatic enzymes: increased values

Skin tests: interference with positive reaction to dermal reactivity indicators

Patient monitoring

• Monitor hepatic and renal function test results.

Patient teaching

• Tell patient he may take drug with or without food.
• Instruct patient to report rapid heartbeat, shortness of breath, rash, persistent flulike symptoms, or muscle ache.
• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.
• As appropriate, review all other significant adverse reactions and interactions, especially those related to the tests mentioned above.


a nonsedating antihistamine (H1 receptor antagonist) used for treatment of allergic rhinitis and chronic idiopathic urticaria. It is administered orally.


A long-acting, low-sedation, ANTIHISTAMINE drug that does not block cardiac potassium channels and is less likely than some second generation antihistamines to have undesirable cardiac effects. It is also less prone to enter the nervous system and produce sedation. A brand name is Neoclarityn.
References in periodicals archive ?
Frost & Sullivan also reported widespread deployment of Aerius equipped phones: "By allowing cellsites to work efficiently by using up to 50% less power, this (Aerius International) technology, when widely deployed, has the potential to reduce cell site CO2 emissions by up to 1.
Toyota Motor Corporation (Toyota) (NYSE: TM) (LSE: TYT) (TYO: 7203), a Japan-based automaker, is unveiling its Prius Aerius concept vehicle at the 2009 SEMA Show in Las Vegas.
Also please note that the Martin Logan Aerius received a highly favorable review in these pages several years ago.
It sounds superb, especially with electrostatics like Martin Logan Aerius.
During the period in which I was reviewing the 50s, I had the chance to audition some Martin-Logan Aerius hybrid cone woofer/electrostatic mid/tweeter systems, also running through a Linn Wakonda preamp and Klout amplifier.
OTC: GOHG) announces a consulting agreement with Rich Keys Consultants and Aerius International, Inc.
Aerius won the 2009 Frost & Sullivan Green Technology Award because its phones eliminate cell phone radiation absorbed by users, causing Aerius phones to operate using less power, that delivers 2 to 4 more hours to their battery life compared to other phones sold worldwide.
20, 2011 /PRNewswire/ -- Aerius International, Inc.
European Commission Approves AERIUS (R) Orodispersible Tablets (2.
While this has not been tested, Aerius won a 2009 Frost & Sullivan Award in Wireless Technologies due in part to CTIA Authorized lab tests that show Aerius eliminates SAR (the specific absorption rate of phone microwave radiation into users) 96.